BEIJING: Several antiviral drugs have been applied in clinical trials against the Covid-19 disease (coronavirus), and some have shown fairly good clinical efficacy, according to an official on Saturday (Feb 15).
Chinese researchers have narrowed down their focus to a few existing drugs, including Chloroquine Phosphate, Favipiravir and Remdesivir, after multiple rounds of screening, said Zhang Xinmin, director of the China National Centre for Biotechnology Development under the Ministry of Science and Technology, at a press conference on the new virus.